FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma
International Journal of General Medicine · 2023-02 · Volume 16 · 467-480
DOI: 10.2147/ijgm.s395881 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2023-02. Verfasst von Kai-Wen Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
- Department of Hepatobiliary Surgery, the People's Hospital of Rongchang District, Chongqing, People's Republic of China.
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
ORCID-Profile: Kai-Wen Zheng, Chun-Ming Li
Zitieren
APA
Zheng, K. W., Zhang, C. H., Wu, W., Zhu, Z., Gong, J. P., & Li, C. M. (2023). FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma. International Journal of General Medicine, Volume 16, 467-480. https://doi.org/10.2147/ijgm.s395881
Vancouver
Zheng KW, Zhang CH, Wu W, Zhu Z, Gong JP, Li CM. FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma. International Journal of General Medicine. 2023;Volume 16:467-480. doi:10.2147/ijgm.s395881
BibTeX
@article{Zheng2023,
author = {Zheng, Kai-Wen and Zhang, Chao-Hua and Wu, Wu and Zhu, Zhu and Gong, Jian-Ping and Li, Chun-Ming},
title = {FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma},
journal = {International Journal of General Medicine},
year = {2023},
volume = {Volume 16},
pages = {467--480},
doi = {10.2147/ijgm.s395881}
}
EUVIMED